Navigation Links
Cardium Reports On Third Quarter 2013 Financial Results And Recent Business Developments
Date:11/19/2013

  • New FDA 510(k) submission for Cardium's current FDA-cleared Excellagen to reflect additional and specific structural and functional properties based on the Company's supplemental research and development activities.
  • Research collaborations with (1) Orbsen Therapeutics Ltd and the National University of Ireland, Galway, to utilize Excellagen in pre-clinical studies as a delivery agent for Orbsen's proprietary stromal cell therapy for the potential treatment of diabetic foot ulcers, and (2) researchers at Boston Children's Hospital, to assess the medical utility of Excellagen as a scaffold to seed autologous mesenchymal fetal stem cells for ex-vivo engineering of tissue grafts for transplantation into infants to potentially repair prenatally diagnosed birth defects.
  • Completion of a 1:20 reverse stock split of the Company's common stock and closing of the second tranche of the securities purchase agreement with one of its institutional investors consisting of 1,656 shares of Series A convertible preferred stock for gross proceeds of approximately $1.7 million, both of which were approved at the 2013 annual meeting of stockholders.
  • Instituted a series of cost reduction actions that include relocation of the corporate offices to a smaller and lower cost facility, reduced employee headcount and across the board salary reductions. The impact of these measures will be reflected in the fourth quarter.
  • (Logo: http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO)

    Report on LifeAgain Advanced Medical AnalyticsDuring the third quarter, LifeAgain Insurance Solutions, Inc., Cardium's newly-formed advanced medical data analytics business focused on the development, marketing and sale of "survivable risk" term life insurance programs, and AgencyONE, its commercialization partner, entered into agreements to market and sell term life insurance issued by Symetra Lif
    '/>"/>

    SOURCE Cardium Therapeutics
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

    Related medicine technology :

    1. Unusual Trading Activity In Cardium Common Stock
    2. Cardium Reports On Potential Use Of Excellagen To Repair Prenatally Diagnosed Birth Defects Using Mesenchymal Stem Cells
    3. Cardium Announces New Excellagen FDA 510(k) Submission Based On Expanded Structural And Functional Properties
    4. Cardium Reports On New Excellagen Distribution Agreement With AvKARE For Veterans Hospitals And Other Governmental Medical Facilities
    5. Cardium Completes Preferred Stock Financing
    6. Cardium Announces Reverse Stock Split
    7. Cardium Announces Initial Voting Results And Temporary Adjournment of Annual Meeting To Be Reconvened On June 21, 2013
    8. Cardium Presents First Quarter 2013 Financial Results And Reports On Recent Developments
    9. Cardium Announces Generx Publication In Molecular Therapy
    10. Cardium Announces Excellagen Presentation at the Symposium on Advanced Wound Care Spring 2013 Meeting
    11. Cardium Presents Year-End 2012 Financial Results And Recent Developments
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/30/2015)... , June 30, 2015  Ardelyx, Inc. (NASDAQ: ... cardio-renal, gastrointestinal and metabolic diseases, today announced that the ... 14, 2015, from 8:00 a.m.- 1:00 pm EDT in ... The Ardelyx senior management team will present an ... compound, tenapanor, which has completed Phase 2b clinical trials ...
    (Date:6/30/2015)... JERUSALEM , June 30, 2015 ... http://www.oramed.com ), a clinical-stage pharmaceutical Company focused on the ... the first patient has been screened in the Company,s ...  This U.S. based study will be performed under the ... the U.S. Food and Drug Administration (FDA). ...
    (Date:6/30/2015)... 2015 /PRNewswire/ – Small Cap IR issues report. Recently, ... custom Arrayit blood card technology to Vivos, Global Genome ... Vivos offers an impervious, impenetrable and permanent DNA storage ... child on Earth, a safe and secure nuclear blast-proof, ... allow the rapid collection, separation, drying and storage of ...
    Breaking Medicine Technology:Ardelyx to Host Inaugural R&D Investor Day in New York City on July 14, 2015 2Oramed Enrolls First Patient in its Phase IIb Oral Insulin Study 2Oramed Enrolls First Patient in its Phase IIb Oral Insulin Study 3Small Cap IR - Empowering the Age of Genetic Enlightenment 2
    (Date:6/30/2015)... Angeles, CA (PRWEB) , ... June 30, 2015 , ... ... You Have Acne ,” listed five triggers that most people would not expect ... hair care products, and toothpaste. The primary causes of acne are clogged ...
    (Date:6/30/2015)... Denver,CO (PRWEB) , ... June 30, 2015 , ... ... the 26th Annual Alzheimer's Association of Colorado's Education Symposium on November 9, 2015 ... Association is honored to host a conversation with Kim and Ashley Campbell, the ...
    (Date:6/30/2015)... ... June 30, 2015 , ... Dr. Sammy Masri of Masri Sports Medicine &Wellness, ... in the diagnosis and treatment of non-surgical sports and other musculoskeletal injuries for both ... recreational athletics and use exercise to stay healthy and active. Dr. Masri seeks to ...
    (Date:6/30/2015)... ... June 30, 2015 , ... CCAR is pleased to announce ... Centers in Hartford, Willimantic and Bridgeport. This month, staff member Jim Higgins left ... Manager. He is excited to take on this role of organizing peer recovery ...
    (Date:6/30/2015)... ... June 30, 2015 , ... Independence Day weekend is more than ... and official kick off of July as National Hot Dog Month. Americans are expected ... any other time of the year and enough to stretch from Washington D.C. to ...
    Breaking Medicine News(10 mins):Health News:A List of 5 Surprising Acne Triggers and the Latest Acne Treatment Options 2Health News:Family of Singer Glen Campbell to Discuss Living with Dementia at the Alzheimer's Association of Colorado's 26th Annual Education Symposium 2Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 2Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 3Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 4Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 5Health News:The Connecticut Community for Addiction Recovery takes Recovery Coaching to a new level 2Health News:Biggest Hot Dog Weekend of the Year to Kick Off National Hot Dog Month 2
    ... of injection drug users (IDUs) in Baltimore found a significant ... slight decline in new cases of hepatitis C virus (HCV) ... of these viral infections have had success but must be ... School of Public Health and other centers, led by Shruti ...
    ... News) -- Dry eye syndrome is common in winter because ... an eye expert. Symptoms include pain, blurred vision, a ... eyes try to compensate for the dryness, explains Pittsburgh-area ophthalmologist ... can cause watery eyes, differentiating the two conditions can be ...
    ... hormone therapy at around the time of menopause is associated ... after a longer gap, according to a study published online ... Cancer Institute. In this large, prospectively followed cohort of ... after menopause had little or no increased risk, regardless of ...
    ... prostate cancer surgery may help activate the body,s immune ... in lowering mood disturbance, according to a new study ... Cancer Center. The study is published in ... . It,s the first to examine the effects pre-surgery ...
    ... -- Rheumatoid arthritis (RA) patients with low socioeconomic status are ... Previous research has shown that 13 percent to 42 percent ... outcomes. In this new study, researchers analyzed data from ... and found that 37 percent of them had moderate to ...
    ... School (UMMS) and Lundbeck Inc. today announced a research ... to slow or halt the progression of Huntington,s disease ... way to stop or reverse the course of HD, ... of progressive motor, cognitive and emotional symptoms. This collaboration ...
    Cached Medicine News:Health News:Study finds little decline in hepatitis C infections among injection drug users 2Health News:Dry Eye Syndrome Common in Winter 2Health News:Hormone therapy begun at menopause may pose risk for breast cancer 2Health News:Pre-surgical stress management boosts immune function, lowers mood disturbance in prostate cancer patients 2Health News:Pre-surgical stress management boosts immune function, lowers mood disturbance in prostate cancer patients 3Health News:Depression in Rheumatoid Arthritis Patients Linked to Social Status 2Health News:UMMS and Lundbeck to explore potential targeted therapy for Huntington's disease 2Health News:UMMS and Lundbeck to explore potential targeted therapy for Huntington's disease 3
    The SB Charit is a prosthesis system consisting of two endplates made of high quality cobalt chromium alloy with an ultra high molecular weight polyethylene sliding core placed between them....
    ... The D185 is ... FDA clearance for this ... transcranial motor evoked potentials ... surgical procedures such as ...
    High temperature loop tip cautery....
    Strongly curved 90 degree, working part 200 mm....
    Medicine Products: